|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date / Period | Status |
|---|---|---|
| Fibromyalgia | 14-Mar-2016 | active |
| Seizure disorder | 26-Dec-1998 | active |
| Acute bronchitis | 12-Aug-2020 - 25-Aug-2020 | inactive |
| Sprain of ankle | 15-Apr-2017 - 06-May-2017 | inactive |
| Acute bronchitis | 06-Feb-2016 - 24-Feb-2016 | inactive |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| Fentanyl 25 microgram/hour prolonged-release transdermal patch | 2025-05-24 | - | 25 microgram/hour patch applied every 72 hours | - |
| Oxycodone hydrochloride 10 mg prolonged-release oral tablet | 2025-05-24 | - | 1 tablet (10 mg) every 12 hours | - |
| Acetaminophen 325 mg and oxycodone hydrochloride 10 mg oral tablet | 2025-05-24 | - | 1 tablet (325 mg/10 mg) by mouth every 4 to 6 hours as needed for pain | - |
| Hydrocodone bitartrate 10 mg and ibuprofen 200 mg oral tablet | 2025-05-24 | - | 1 tablet (10 mg/200 mg) every 4 to 6 hours as needed | - |
| Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet | 2016-06-28 | - | 1 tablet (300 mg/5 mg) every 4 to 6 hours as needed for pain | - |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 24-May-2025 |
| Hepatitis B virus antigen only vaccine product | 25-Apr-2020 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 20-Apr-2019 |
| Neisseria meningitidis antigen-containing vaccine product | 20-Apr-2019 |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 13-Feb-2016 | - |
| Assessment of health and social care needs | 13-Feb-2016 | - |
Allergies and Intolerances
| No known allergies or intolerances |
Care Plan
| Active Planned Care / Goals | Start Date | Reason |
|---|---|---|
| Therapy | 29-Apr-2016 | - |
Vital Signs
| Vital Signs | 2025-05-24 | 2024-05-18 |
|---|---|---|
| Body Height | 179.2 cm | 179.2 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 {score} | 3 {score} |
| Body Weight | 124.4 kg | 124.4 kg |
| Body mass index (BMI) [Ratio] | 38.7 kg/m2 | 38.7 kg/m2 |
| Heart rate | 75 /min | 81 /min |
| Respiratory rate | 12 /min | 13 /min |
| Blood pressure panel with all children optional | 77 mm[Hg] | 77 mm[Hg] |
Relevant diagnostic tests/laboratory data
| Recent Lab Observations | 18-MAY-2024 | Reference Range | Unit |
|---|---|---|---|
| Leukocytes [#/volume] in Blood by Automated count | 10.0 | 4.5 - 11.0 | 10*3/uL |
| Erythrocytes [#/volume] in Blood by Automated count | 5.2 | 4.5 - 5.9 | 10*6/uL |
| Hemoglobin [Mass/volume] in Blood | 16.5 | 13.5 - 17.5 | g/dL |
| Hematocrit [Volume Fraction] of Blood by Automated count | 36.2 | 36 - 50 | % |
| MCV [Entitic mean volume] in Red Blood Cells by Automated count | 93.2 | 80 - 100 | fL |
| MCH [Entitic mass] by Automated count | 28.8 | 27 - 33 | pg |
| MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count | 34.2 | 32 - 36 | g/dL |
| Erythrocyte distribution width [Entitic volume] by Automated count | 43.5 | 36 - 48 | fL |
| Platelets [#/volume] in Blood by Automated count | 248.6 | 150 - 450 | 10*3/uL |
| Platelet distribution width [Entitic volume] in Blood by Automated count | 189.3 H | 9.4 - 12.3 | fL |
| Platelet [Entitic mean volume] in Blood by Automated count | 9.9 | 7.4 - 10.4 | fL |
Device Use
| No known devices |